ID: ALA5218527

Max Phase: Preclinical

Molecular Formula: C18H28N2O3S

Molecular Weight: 352.50

Associated Items:

Representations

Canonical SMILES:  CC1CCN(CCC2CCCN2S(=O)(=O)c2cccc(O)c2)CC1

Standard InChI:  InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3

Standard InChI Key:  HWKROQUZSKPIKQ-UHFFFAOYSA-N

Associated Targets(Human)

Serotonin 7 (5-HT7) receptor 5576 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 352.50Molecular Weight (Monoisotopic): 352.1821AlogP: 2.67#Rotatable Bonds: 5
Polar Surface Area: 60.85Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.21CX Basic pKa: 8.95CX LogP: 1.52CX LogD: 1.00
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.88Np Likeness Score: -1.31

References

1. Kucwaj-Brysz K, Baltrukevich H, Czarnota K, Handzlik J..  (2021)  Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer's disease.,  49  [PMID:34311086] [10.1016/j.bmcl.2021.128275]

Source